Novartis Ag

Ciba-geigy Corporation

Novartis Corporation

Nicholas Lowther

Robin Alec Fairhurst

Bernard Cuenoud

Ian Timothy Matthews

Ian Francis Hassan

John D Allen

Colin Howes

A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.

Mixtures or organic compounds for the treatment of airway diseases

Mixtures for organic compounds for the treatment of airway diseases

Desferrioxamine-B salts and their use as orally effective iron chelators

A salt of formula ##STR1## where X denotes a group of formula ##STR2## Y denotes a group of formula ##STR3## and R denotes the residue of an aliphatic or cycloaliphatic sulphonic acid having at least 3 carbon atoms after removal of a --SO.sub.3 H group therefrom.

Desferrioxamine-B salts

The present invention provides a stable aqueous solution of hybrid .alpha.-Interferon which contains as the stabilizer a buffer at a pH of from 3.0 to 5.0.

Pharmaceutical compositions comprising hybrid .alpha.-interferon

Growing community of inventors

Horsham, United Kingdom

Nicholas Lowther